Australasia’s Premier Infectious Diseases Conference
Come enjoy autumn in Launceston for the Annual Australasian Society for Infectious Diseases (ASID) Annual Scientific Meeting (ASM) from 20 – 23 April 2016.
The ASID ASM is all about connecting and exchanging: connecting clinicians, microbiologists and other health professionals with a common interest in infectious diseases and providing a friendly forum for the exchange of scientific advances in the prevention, diagnosis and management of clinical infectious diseases.
And what better place to do this than in Launceston, the beautiful boutique riverside city at the head of the Tamar Valley that boasts magnificent natural attractions including the spectacular Cataract Gorge Reserve and beautiful parks and gardens. Immerse yourself in the city’s rich cultural heritage, and thriving food and wine scene set amongst the backdrop of vibrant Georgian streetscapes.
A Compelling Program
The 2016 Conference program will focus on providing an innovative and comprehensive review of the latest developments in the rapidly expanding fields of antimicrobial stewardship, infection control, viral hepatitis and more.
Renowned International and National Speakers
Three international speakers will accompany the national line up of experts, to present recent and relevant global and local scientific research through a series of keynote lectures, proffered papers, symposia and educational workshops.
The MacFarlane Burnet Speaker 2016
Professor Alison Holmes, UK
Alison Holmes is a Professor of Infectious Diseases and Director of Infection Prevention and Control (DIPC) for Imperial College Healthcare NHS Trust in the UK. She is also Director of the NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infection and Antimicrobial Resistance and Co-Director of the UKCRC funded National Centre for Infection Prevention and Management.
International Keynote Speakers 2016
Professor David Kimberlin, USA
Prof Kimberlin is Co-Director of the Division of Paediatric Infectious Diseases at the University of Alabama, Birmingham, USA. He is Principal Investigator of the Collaborative Antiviral Study Group (CASG), and on the CASG’s four newly awarded contracts of $19.2M to evaluate novel therapeutic and diagnostic opportunities for management of neonatal herpes simplex virus (HSV) disease and congenital cytomegalovirus (CMV) infection.
Professor Gavin Screaton, UK
Prof Screaton is the Chair of Medicine at Imperial College.
His research has covered a variety of topics from control of RNA processing and apoptosis to immunology. The current interests of his laboratory revolve around the immunology of infectious diseases with a special interest in dengue haemorrhagic fever, with active research collaborations in South-East Asia.
Plenary Speaker 2016
Professor Sharon Lewin, AUS
Prof Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a consultant ID physician at the Alfred Hospital in Melbourne, and an NHMRC Practitioner Fellow.
She leads a large multi-disciplinary research team that focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection . Her other research and clinical interests include immune reconstitution and immune activation post antiretroviral therapy and HIV-hepatitis B virus co-infection.
Facilitation of Special Interest Groups
The conference format provides local special interest groups with the opportunity to come together during the meeting. These include the
- Paediatric Special Interest Group (ANZPID)
- Healthcare Infection Control Special Interest Group (HICSIG)
- Mycology Special Interest Group (ANZMIG)
- Viral Hepatitis Special Interest Group (VHSIG)
Activities and Fun
Launceston is a charming and friendly city to visit and provides a wonderful opportunity for you and colleagues to explore the many great attractions that Tasmania has to offer at the same time as expanding professional skills and networks.
Register for the conference now. Visit www.asid.net.au/meetings/annual-scientific-meeting-2016
Patients will have increased access to the latest oncology treatment technology and research,...
A review of more than 40 studies on coronavirus immunity suggests that SARS-CoV-2 could become...
A UK study has revealed that age, male sex, obesity and underlying illness emerge as risk factors...